PHASE II TRIAL OF GVHD PROPHYLAXIS WITH POST-TRANSPLANTATION CYCLOPHOSPHAMIDE FOLLOWING REDUCED-INTENSITY BUSULFAN/FLUDARABINE (BU/FLU) CONDITIONING FOR HEMATOLOGICAL MALIGNANCIES

GVHD-prophylaxis with post-transplant cyclophosphamide (CY) following ablative HLA-matched bone marrow (BM) transplantation has been reported to have comparable rates of acute GVHD with an apparent reduction in chronic GVHD and infections. We conducted a phase II trial of post-CY following reduced-i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biol Blood Marrow Transplant
Hauptverfasser: Alousi, Amin M., Brammer, Jonathan E., Saliba, Rima M., Andersson, Borje, Popat, Uday, Hosing, Chitra, Jones, Roy, Shpall, Elizabeth J, Khouri, Issa, Qazilbash, Muzaffar, Nieto, Yago, Shah, Nina, Ahmed, Sairah, Oran, Betul, Atrash, Gheath Al, Ciurea, Stefan, Kebriaei, Partow, Chen, Julianne, Rondon, Gabriela, Champlin, Richard
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2015
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4825327/
https://ncbi.nlm.nih.gov/pubmed/25667989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.01.026
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge